Jan Stenvang

Title: Inventor Profile: Jan Stenvang

Introduction

Jan Stenvang is an innovative inventor based in Copenhagen, Denmark. He has made significant contributions to the field of cancer treatment, holding two patents that focus on methods to improve the efficacy of anti-cancer therapies.

Latest Patents

Jan Stenvang’s latest patents involve a groundbreaking approach to cancer treatment. One of his notable inventions relates to methods of sensitizing cancer cells to anti-cancer therapies by administering an effective amount of a modulator of Volume Regulated Anion Channels, commonly referred to as a VRAC modulator. This unique combination treatment aims to enhance the effects of current cancer therapies, potentially improving patient outcomes.

Career Highlights

Stenvang contributes his expertise at Scandion Oncology A/S, a company dedicated to advancing cancer treatment through innovative research and development. His role at the company showcases his commitment to improving health outcomes for cancer patients through scientific discoveries.

Collaborations

Throughout his career, Jan Stenvang has worked alongside esteemed colleagues, including Nils Aage Brünner and Palle Christophersen. These collaborations demonstrate his ability to synergize with other professionals in the research community, combining knowledge and expertise to drive forward the development of effective cancer treatments.

Conclusion

Jan Stenvang's work in the field of cancer therapy represents a vital contribution to medical innovations. With his innovative patents and collaborations with esteemed professionals, he continues to push the boundaries of cancer treatment, providing hope for improved therapies and healing outcomes for patients.